Clinical study of acupoint application in the treatment of slow sinus arrhythmia

注册号:

Registration number:

ITMCTR2000003739

最近更新日期:

Date of Last Refreshed on:

2020-08-26

注册时间:

Date of Registration:

2020-08-26

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

穴位敷贴法治疗缓慢型窦性心律失常的临床研究

Public title:

Clinical study of acupoint application in the treatment of slow sinus arrhythmia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

穴位敷贴法治疗缓慢型窦性心律失常的临床研究

Scientific title:

Clinical study of acupoint application in the treatment of slow sinus arrhythmia

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000037050 ; ChiMCTR2000003739

申请注册联系人:

乔思雨

研究负责人:

乔思雨

Applicant:

Si-Yu Qiao

Study leader:

Si-Yu Qiao

申请注册联系人电话:

Applicant telephone:

+86 13917412133

研究负责人电话:

Study leader's telephone:

+86 13917412133

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1934131@163.com

研究负责人电子邮件:

Study leader's E-mail:

1934131@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宛平南路725号龙华医院心病科

研究负责人通讯地址:

上海市徐汇区宛平南路725号龙华医院心病科

Applicant address:

725 Wanping Road South, Xuhui District, Shanghai, China

Study leader's address:

725 Wanping Road South, Xuhui District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

200032

研究负责人邮政编码:

Study leader's postcode:

200032

申请人所在单位:

上海中医药大学附属龙华医院

Applicant's institution:

Cardiovascular Department, Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020LHSB075

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

上海中医药大学附属龙华医院医学伦理委员会

Name of the ethic committee:

Institutional Review Board Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020/8/14 0:00:00

伦理委员会联系人:

刘蕾

Contact Name of the ethic committee:

Lei Liu

伦理委员会联系地址:

上海市徐汇区宛平南路725号龙华医院

Contact Address of the ethic committee:

725 Wanping Road South, Xuhui District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 021-64385700-1318

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海中医药大学附属龙华医院

Primary sponsor:

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

上海市徐汇区宛平南路725号

Primary sponsor's address:

725 Wanping Road South, Xuhui District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

具体地址:

徐汇区宛平南路725号龙华医院

Institution
hospital:

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Address:

725 Wanping Road South, Xuhui District

经费或物资来源:

上海申康医院发展中心

Source(s) of funding:

Shanghai Shenkang Hospital Development Center

研究疾病:

缓慢型窦性心律失常

研究疾病代码:

Target disease:

slow sinus arrhythmia

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

评价穴位敷贴治疗缓慢型窦性心律失常的临床疗效及安全性

Objectives of Study:

To evaluate the clinical efficacy and safety of acupoint application in treating slow sinus arrhythmia

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合缓慢型窦性心律失常西医诊断标准及上述中医证候诊断标准,年龄在 18~90岁之间的患者; (2)患者知情同意、自愿参加; (3)签署知情同意书。

Inclusion criteria

(1) Patients aged between 18 and 90 who meet the diagnostic criteria of slow sinus arrhythmia and the above diagnostic criteria of TCM syndromes; (2) Informed consent and voluntary participation of the patient; (3) Sign informed consent.

排除标准:

(1)年龄在18岁以下或90岁以上的患者,妊娠或哺乳期妇女; (2)无明显不适症状的窦性心动过缓患者; (3)病态窦房结综合征表现为慢-快综合征,同时伴阿-斯综合征或晕厥先兆的患者; (4)安装或符合植入永久起搏器的患者; (5)有低血压、休克等严重血流动力学不稳定等合并症的患者; (6)合并心脑肝肾及造血系统等严重原发疾病、精神病的患者; (7)甲状腺功能减退、颅内病变等非心脏疾病继发性引起心动过缓的患者; (8)服用可引起心动过缓药物如β受体阻滞剂、洋地黄制剂等的患者; (9)过敏体质或多种药物过敏者; (10)采用西药治疗本病的患者; (11)正参加其它临床研究的病人。

Exclusion criteria:

(1) A patient under 18 or over 90 years of age, a pregnant or lactating woman; (2) Sinus bradycardia without obvious symptoms of discomfort; (3) Patients with sick sinus syndrome presenting as slow-fast syndrome accompanied by a-s syndrome or syncope; (4) Patients installed or fitted with permanent pacemakers; (5) Patients with severe hemodynamic instability such as hypotension and shock; (6) Patients with severe primary diseases such as heart, brain, liver, kidney and hematopoietic system; (7) Patients with secondary bradycardia caused by non-cardiac diseases such as hypothyroidism and intracranial lesions; (8) Patients taking bradycardia drugs such as β receptor blockers and digitalis preparations; (9) Allergic constitution or multi-drug allergy; (10) Patients treated with western medicine; (11) Patients participating in other clinical studies.

研究实施时间:

Study execute time:

From 2020-10-01

To      2022-09-30

征募观察对象时间:

Recruiting time:

From 2020-10-01

To      2022-09-30

干预措施:

Interventions:

组别:

对照组

样本量:

36

Group:

control group

Sample size:

干预措施:

模拟剂穴位敷贴

干预措施代码:

Intervention:

Simulator acupoint application

Intervention code:

组别:

试验组

样本量:

36

Group:

experimental group

Sample size:

干预措施:

吴茱萸粉穴位敷贴

干预措施代码:

Intervention:

Evodia rutaecarpa powder acupoint application

Intervention code:

样本总量 Total sample size : 72

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海中医药大学附属龙华医院

单位级别:

三级甲等

Institution/hospital:

Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

生活质量评分

指标类型:

次要指标

Outcome:

-

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心肺运动试验

指标类型:

主要指标

Outcome:

Cardiopulmonary exercise test

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医症候积分

指标类型:

次要指标

Outcome:

TCM Syndrome Integral

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

24小时心电图

指标类型:

主要指标

Outcome:

24-hour electrocardiogram

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 80
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机编码表由中央随机平台产生

Randomization Procedure (please state who generates the random number sequence and by what method):

Random coded tables are generated by central random platforms

盲法:

双盲

Blinding:

Double blind

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6个月内公开,联系统计师

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Open within 6 months after completion of the test, contact the statistician

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表/电子采集和管理系统。数据管理的标准操作规程研究过程严格按照SOP进行

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record sheet / electronic collection and management system. Data management standard operating procedures research process in strict accordance with the SOP

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above